- Release Date: 22/11/24 08:44
- Summary: First patient dosed in Phase 1b study into obese subjects
- Price Sensitive: No
- Download Document 246.9KB
- Forums
- ASX - By Stock
- TYP
- Ann: First patient dosed in Phase 1b study into obese subjects
TYP
tryptamine therapeutics limited
Add to My Watchlist
6.06%
!
3.5¢

Ann: First patient dosed in Phase 1b study into obese subjects
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.5¢ |
Change
0.002(6.06%) |
Mkt cap ! $48.61M |
Open | High | Low | Value | Volume |
3.1¢ | 3.5¢ | 3.1¢ | $34.50K | 1.044M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 327776 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 966665 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 327776 | 0.033 |
2 | 311500 | 0.032 |
7 | 809856 | 0.031 |
11 | 844354 | 0.030 |
3 | 202280 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 966665 | 4 |
0.036 | 251515 | 2 |
0.037 | 350000 | 2 |
0.038 | 401847 | 2 |
0.039 | 723538 | 4 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
TYP (ASX) Chart |